EMG
GILD icon

Ellington Management Group’s Gilead Sciences GILD Stock Holding History

Ellington Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,400
Closed -$279K – 611
2019
Q3 		$279K Buy
+4,400
New +$288K 0.05% 394
2019
Q2 		– Sell
-4,500
Closed -$293K – 651
2019
Q1 		$293K Sell
4,500
-1,500
-25% -$99.7K 0.05% 367
2018
Q4 		$375K Buy
6,000
+2,700
+82% +$189K 0.11% 192
2018
Q3 		$255K Sell
3,300
-8,200
-71% -$619K 0.07% 375
2018
Q2 		$815K Buy
+11,500
New +$812K 0.06% 94
2018
Q1 		– Sell
-5,900
Closed -$423K – 895
2017
Q4 		$423K Sell
5,900
-1,700
-22% -$129K 0.07% 260
2017
Q3 		$616K Sell
7,600
-2,100
-22% -$161K 0.11% 153
2017
Q2 		$687K Buy
9,700
+5,200
+116% +$346K 0.1% 159
2017
Q1 		$306K Sell
4,500
-1,800
-29% -$127K 0.01% 460
2016
Q4 		$451K Sell
6,300
-1,100
-15% -$81.8K 0.07% 235
2016
Q3 		$585K Buy
+7,400
New +$601K 0.16% 222
2015
Q4 		– Sell
-3,000
Closed -$295K – 674
2015
Q3 		$295K Sell
3,000
-6,900
-70% -$766K 0.08% 417
2015
Q2 		$1.16M Buy
9,900
+3,300
+50% +$361K 0.28% 77
2015
Q1 		$648K Buy
6,600
+500
+8% +$50.8K 0.13% 209
2014
Q4 		$575K Buy
6,100
+1,100
+22% +$114K 0.19% 150
2014
Q3 		$532K Sell
5,000
-1,400
-22% -$137K 0.37% 37
2014
Q2 		$531K Hold
6,400
– – 0.25% 104
2014
Q1 		$454K Buy
6,400
+1,900
+42% +$149K 0.13% 240
2013
Q4 		$338K Sell
4,500
-2,900
-39% -$202K 0.12% 279
2013
Q3 		$465K Sell
7,400
-700
-9% -$41.8K 0.09% 344
2013
Q2 		$415K Buy
+8,100
New +$422K 0.08% 388

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ellington Management Group's GILD Position: Q4 2019 in Review

Ellington Management Group sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 4,400 shares — an estimated $279K sold.

Ellington Management Group first reported a position in GILD in Q2 2013 and held it in 21 quarters. The position peaked at $1.16M in Q2 2015. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Ellington Management Group reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Ellington Management Group sold 4,400 Gilead Sciences shares in Q4 2019, an estimated $279K.
  • Ellington Management Group first reported a position in Gilead Sciences in Q2 2013 and held it in 21 quarters.
  • Ellington Management Group's Gilead Sciences position peaked at $1.16M in Q2 2015.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Ellington Management Group's 13F filing for Q4 2019, filed 14 Feb 2020.